Cryo Cell International Inc
CCEL- Exchange
- NYSE
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0000862692
No open-market purchases or sales by Cryo Cell International Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $1.77M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Cryo Cell International Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −1 vs. Q4 2023
- Shares held
- 874.0K
- +9.52K (+1.1%) vs. Q4 2023
- Total value
- $6.52M
- +$1.55M (+31.2%) vs. Q4 2023
- New holders
- 1
- 3 more added
- Sold out
- 2
- 4 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $1.77M |
| Q1 2026 | 11 | $1.89M |
| Q4 2025 | 17 | $3.38M |
| Q3 2025 | 20 | $4.59M |
| Q2 2025 | 20 | $5.17M |
| Q1 2025 | 21 | $6.57M |
| Q4 2024 | 20 | $7.64M |
| Q3 2024 | 14 | $5.74M |
| Q2 2024 | 14 | $6.82M |
| Q1 2024 | 14 | $6.52M |
| Q4 2023 | 15 | $4.97M |
| Q3 2023 | 12 | $4.43M |
| Q2 2023 | 12 | $5.04M |
| Q1 2023 | 12 | $2.50M |
| Q4 2022 | 14 | $4.33M |
| Q3 2022 | 14 | $4.25M |
| Q2 2022 | 13 | $4.45M |
| Q1 2022 | 12 | $5.70M |
| Q4 2021 | 14 | $10.1M |
| Q3 2021 | 10 | $7.88M |
| Q2 2021 | 3 | $1.30M |
| Q1 2021 | 2 | $895.0K |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Cryo Cell International Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 11 | $82 | 0.00% | +2+22.2% | Added |
| Wells Fargo & Company | 29 | $216 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 74 | $1.00K | 0.00% | −29−28.2% | Reduced |
| Morgan Stanley | 600 | $4.48K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,500 | $18.6K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 12,934 | $96.5K | 0.00% | −316−2.4% | Reduced |
| Rowland & Co Investment Counsel | 14,433 | $107.7K | 0.02% | +14,433 | New |
| Cerity Partners LLC | 19,563 | $145.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 21,428 | $159.9K | 0.00% | +476+2.3% | Added |
| Northern Trust Corp | 23,378 | $174.4K | 0.00% | −2,922−11.1% | Reduced |
| Vanguard Group Inc | 92,939 | $693.3K | 0.00% | +1,800+2.0% | Added |
| Massmutual Trust Co FSB | 111,035 | $828.3K | 0.03% | −3,178−2.8% | Reduced |
| SFI Advisors, LLC | 165,300 | $1.23M | 0.97% | 00.0% | Unchanged |
| Hamilton Lane Advisors LLC | 409,734 | $3.06M | 2.09% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −741−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −2−100.0% | Sold out |